Minerva Surgical, Inc. (UTRS)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Nov 13, 2024

Minerva Surgical Company Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.

The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.

Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices.

The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Minerva Surgical, Inc.
Country United States
Founded 2008
Industry Medical Devices
Sector Healthcare
Employees 174
CEO Darrin Hammers

Contact Details

Address:
4255 Burton Drive
Santa Clara, Delaware 95054
United States
Phone 855 646 7874
Website minervasurgical.com

Stock Details

Ticker Symbol UTRS
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number US60343F1066
SIC Code 3841

Key Executives

Name Position
Darrin Hammers Chief Executive Officer
Greg Simbro Vice President of Finance
Erik Reese Vice President of Sales
Wendy Bowman Vice President of Human Resources
Dr. Evgueni V. Skalnyi M.D. Chief Medical Officer
Joanne Long Vice President of Corporate Controller